Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amarin Corporation PLC (NASDAQ:AMRN)

3.23
Delayed Data
As of Dec 12
 -0.10 / -3.00%
Today’s Change
2.81
Today|||52-Week Range
4.47
+4.87%
Year-to-Date
No recent news for Amarin Corporation PLC.

Today’s Trading

Previous close3.33
Today’s open3.32
Day’s range3.18 - 3.37
Volume2,103,944
Average volume (3 months)1,431,843
Market cap$902.0M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+50.85%
Earnings growth (this year)+47.76%
Earnings growth (next 5 years)-249.00%
Revenue growth (last year)+58.31%
P/E ratioNM
Price/Sales5.05
Price/Book--

Competitors

----
RGNXRegenxbio Inc-2.35-7.97%
MEDPMedpace Holdings Inc+0.60+1.71%
CLXTCalyxt Inc+1.19+5.23%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$129.2M
Annual profit (last year)-$85.8M
Net profit margin-66.38%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John F. Thero
SVP-
Manufacturing Operations
Derek Kalinowski
Corporate headquarters
Dublin, Dublin

Forecasts